These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2245976)

  • 1. Growth hormone treatment in patients with neurosecretory dysfunction.
    Rochiccioli P; Dechaux E; Tauber MT; Pienkowski C; Tiberge M
    Horm Res; 1990; 33 Suppl 4():97-101. PubMed ID: 2245976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency.
    Rochiccioli PE; Tauber MT; Coude FX; Arnone M; Morre M; Uboldi F; Barbeau C
    J Clin Endocrinol Metab; 1987 Aug; 65(2):268-74. PubMed ID: 3110202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone neurosecretory dysfunction. A treatable cause of short stature.
    Spiliotis BE; August GP; Hung W; Sonis W; Mendelson W; Bercu BB
    JAMA; 1984 May; 251(17):2223-30. PubMed ID: 6708271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of pharmacological tests and study of 24-hour growth hormone secretion in the investigation of growth retardation in children: analysis of 257 cases.
    Rochiccioli P; Pienkowski C; Tauber MT; Uboldi F; Enjaume C
    Horm Res; 1991; 35(2):70-5. PubMed ID: 1916656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preservation of dopaminergic and alpha-adrenergic function in children with growth hormone neurosecretory dysfunction.
    Bercu BB; Root AW; Shulman DI
    J Clin Endocrinol Metab; 1986 Oct; 63(4):968-73. PubMed ID: 3018032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation.
    Hokken-Koelega AC; Hackeng WH; Stijnen T; Wit JM; de Muinck Keizer-Schrama SM; Drop SL
    J Clin Endocrinol Metab; 1990 Sep; 71(3):688-95. PubMed ID: 2394775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone secretory status evaluated by growth hormone peak after two pharmacological growth hormone release stimuli did not significantly influence the two-year catch-up growth induced by growth hormone therapy in 318 prepubertal short children with idiopathic growth retardation.
    Carrascosa A; Audí L; Fernández-Cancio M; Yeste D; Gussinye M; Albisu MA; Clemente M; Fábregas A; Bel J; Nosás R; Rabanal M; del Pozo C; Gómez JM; Mesa J;
    Horm Res Paediatr; 2011 Feb; 75(2):106-14. PubMed ID: 20975249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth enhancement by dopaminergic therapy in children with intrauterine growth retardation.
    Huseman CA
    J Clin Endocrinol Metab; 1985 Sep; 61(3):514-9. PubMed ID: 3926809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of growth hormone secretion in patients with intrauterine growth retardation.
    Rochiccioli P; Tauber M; Moisan V; Pienkowski C
    Acta Paediatr Scand Suppl; 1989; 349():42-6; discussion 53-4. PubMed ID: 2501968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion.
    Bercu BB; Shulman D; Root AW; Spiliotis BE
    J Clin Endocrinol Metab; 1986 Sep; 63(3):709-16. PubMed ID: 3525601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous dopaminergic dysfunction: a novel form of human growth hormone deficiency and short stature.
    Huseman CA; Hassing JM; Sibilia MG
    J Clin Endocrinol Metab; 1986 Mar; 62(3):484-90. PubMed ID: 3080463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of growth hormone secretion and action in growth-retarded children with juvenile chronic arthritis (JCA).
    Tsatsoulis A; Siamopoulou A; Petsoukis C; Challa A; Bairaktari E; Seferiadis K
    Growth Horm IGF Res; 1999 Apr; 9(2):143-9. PubMed ID: 10373347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic growth hormone administration does not suppress endogenous growth hormone secretion in patients with neurosecretory growth hormone dysfunction.
    Zadik Z; Limoni Y; Lieberman E
    Horm Res; 1991; 35(3-4):95-8. PubMed ID: 1806474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM; Bin-Abbas BS; Kaplan SL
    Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The growth hormone and somatomedin axis in short children with osteogenesis imperfecta.
    Marini JC; Bordenick S; Heavner G; Rose S; Hintz R; Rosenfeld R; Chrousos GP
    J Clin Endocrinol Metab; 1993 Jan; 76(1):251-6. PubMed ID: 8421094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
    Hokken-Koelega AC; Stijnen T; De Jong MC; Donckerwolcke RA; De Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of the parameters of 24-hour growth hormone secretion with growth velocity in 93 children of varying height.
    Rochiccioli P; Messina A; Tauber MT; Enjaume C
    Horm Res; 1989; 31(3):115-8. PubMed ID: 2744724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of physiological growth hormone (GH) secretion in idiopathic short stature after recombinant GH therapy.
    Wu RH; St Louis Y; DiMartino-Nardi J; Wesoly S; Sobel EH; Sherman B; Saenger P
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1612-5. PubMed ID: 2347896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone (GH) treatment in short normal children: absence of influence of time of injection and resistance to GH autofeedback.
    Chanoine JP; Vanderschueren-Lodeweyckx M; Maes M; Thiry-Counson G; Craen M; Van Vliet G
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1269-75. PubMed ID: 1955508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.